Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under BioRestorative Therapies, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Mika Grasso, Chief Executive Officer (Form 8-K filed 2026-09-02). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Auctus Fund, LLC (filed 2026-05-15).
Who is behind it
BioRestorative Therapies, Inc.: incorporated in Nevada; business address in Melville, New York; industry Services-Misc Health & Allied Services, NEC (Form D, 2026-09-02).
Officers and directors, each with the role and the filing that names them:
- Lance Alstodt: Director, Executive Officer (Form D, 2025-10-09)
- Francisco Silva: Director, Executive Officer (Form D, 2025-10-09)
- Robert Kristal: Executive Officer (Form D, 2025-10-09)
- David A Rosa: Director (Form D, 2025-10-09)
- Patrick F Williams: Director (Form D, 2025-10-09)
- Nickolay V Kukekov: Director (Form D, 2025-10-09)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-03 | Alta Partners LLC | 4.9% |
| Schedule 13G/A, 2026-05-15 | Auctus Fund, LLC | 9.9% |
| Schedule 13G/A, 2026-02-23 | Morrison Todd Hale | 0% |
| Schedule 13G, 2026-02-18 | Mitchell P. Kopin | 4.1% |
| Schedule 13G/A, 2026-02-17 | Auctus Fund, LLC | 9.9% |
| Schedule 13G, 2026-02-13 | Alta Partners LLC | 7.7% |
| Schedule 13G/A, 2025-12-19 | Morrison Todd Hale | 7.7% |
| Schedule 13G/A, 2025-08-14 | Auctus Fund, LLC | 9.9% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-09-02 | Mika Grasso | Chief Executive Officer | appointed | |
| Form 8-K, 2026-09-02 | Steven Brown | Chairman of the Board | appointed | |
| Form 8-K, 2026-07-16 | David Rosa | Director | departed | |
| Form 8-K, 2026-07-16 | Katharyn Field | Chief Executive Officer | appointed | 2026-07-13 |
| Form 8-K, 2026-07-16 | Esha Randhawa | Director | appointed | |
| Form 8-K, 2026-06-12 | Mika Grasso | Director | appointed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-10-09 | $1.40M | $1.40M |
Latest IPO step: BioRestorative Therapies, Inc. filed its final IPO prospectus, ticker BRTX (424B4, 2026-02-13).
IPO filings: 424B4, 2026-02-13, S-1/A, 2026-02-10, S-1, 2026-02-09, S-1, 2025-11-18; ticker BRTX on Nasdaq Capital Market.
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/biorestorative-therapiesLast updated 2026-10-18
Primary record: Schedule 13G/A, 2026-05-15 · Form D, 2025-10-09 · Form 8-K, 2026-09-02 · Form 8-K, 2026-07-16
Who owns BioRestorative Therapies, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/biorestorative-therapies